Blue Oak Pharmaceuticals is Drug Discovery in United States that focus on paradigm integrates business. Founded in 2016. They cover business area such as developer, medicine, brain disorder treatment, custom-design privileged chemotype, cut-edge technology, behavioral profiling, synthetic chemistry, brain imaging, patient, rapid clinical confirmation, system-level neurobiology measure, translational biomarker.
2016
( 8 years old in 2024 )
Paradigm Integrates
-
101 Holden Wood Road
Concord, MA 01742
United States
Private
developermedicinebrain disorder treatment, custom-design privileged chemotypecut-edge technologybehavioral profilingsynthetic chemistrybrain imagingpatientrapid clinical confirmationsystem-level neurobiology measuretranslational biomarker
* We use standard office opening hours in near Blue Oak Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Blue Oak Pharmaceuticals is Drug Discovery business from United States that founded in 2016 (8 years old in 2024), Blue Oak Pharmaceuticals business is focusing on Paradigm Integrates.
Blue Oak Pharmaceuticals headquarter office and corporate office address is located in 101 Holden Wood Road Concord, MA 01742 United States.
Blue Oak Pharmaceuticals was founded in United States.
In 2024, Blue Oak Pharmaceuticals is currently focus on paradigm integrates sector.
Above is snippet of Google Trends for "paradigm integrates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Blue Oak Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
